To define the underlying mechanism by which FoxO3 functions in hepatic steatosis, we transfected siRNA into HepG2 cells for knockdown of FoxO3 and examined the mRNA levels of genes involved in hepatic TG metabolism. This evidence concerns the gene FOXO3 and fatty liver disease.